The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
Recent studies have suggested that sugar substitutes might not be the free lunch they're advertised as. We asked experts what ...
Ethics committees and funding agencies often receive protocols that involve either too many or too few animals to answer the specific research question being investigated. It is evident that a greater ...
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...
TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D projects ...
Statin come with heavy baggage. I decided to treat a knowledge gap using my own body in a blinded crossover ...
The frequency of DTH reactions increased by approximately 4x (290%) in the total open-label non-HLA-A*02 population, increasing from 5.2% of the patients experiencing a DTH reaction at baseline, prior ...
Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research ...
Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research ...
In an interview with Targeted Oncology, Naomi Haas, MD, discusses the evolving landscape of adjuvant and neoadjuvant immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results